The Centers for Disease Control and Prevention (CDC) has recently acknowledged that it recommended COVID-19 vaccines for individuals who had already recovered from the virus, without having access to the underlying data. This revelation came in response to a Freedom of Information Act (FOIA) request regarding the CDC’s claim that unvaccinated individuals with previous infection were five times more likely to contract COVID-19 than vaccinated individuals. The CDC’s recommendation was based on a study that had conflicts of interest, with some authors sponsored by pharmaceutical companies involved in vaccine production. The CDC now admits that the data is no longer available, leaving both the CDC and the public in the dark about the study’s findings.
In economic news, the Bureau of Labor Statistics (BLS) has adjusted the Consumer Price Index (CPI) methodology following a two-year issue with the health insurance CPI. The adjustments resulted in a 1.1% increase in the health insurance CPI for October, following 12 months of significant decreases. The BLS has now included “smoothening” and increased the frequency of retained-earnings data in the index, which may result in larger increases in the future. However, the year-over-year change is still distorted due to the previous collapse, leading to a significant understatement of core CPI and core services CPI for the past year.
In a separate development, a report by the House Select Subcommittee on the CCP reveals that the Chinese owner of a makeshift biolab in California, Jia Bei Zhu, has ties to the People’s Republic of China (PRC) and a Chinese military program. Zhu was arrested for distributing misbranded medical devices and lying to the FDA. The lab was discovered when a local code enforcement officer noticed a garden hose attached to the facility. Zhu’s involvement in PRC government-controlled companies and his confession of operating his companies to further PRC policy raise concerns about espionage and intellectual property theft.
Lastly, a recent report discusses the significant rise in autism rates in the United States over the past 50 years, with the current rate being 1 in 36 children. The report suggests that this increase cannot be solely attributed to genetic factors, as genetic studies explain at most 38% of autism cases. The report also explores the societal and economic costs of autism, emphasizing the financial burden it places on families and the healthcare system. The report suggests that vaccines may be a significant contributor to autism risk, citing studies that show an association between vaccines and autism. The report criticizes the CDC, EPA, NIH, and the pharmaceutical industry for their handling of vaccine-related issues, accusing them of manipulating findings and destroying data.